Delivery Order SPE2DB24D2105-SPE2DB26FANUR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units) valued at $4,050.39. This firm fixed-price contract, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Nucynta ER 250 mg tablets (60-count units) with a contract value of $30,366.81. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $1,181.68 under a firm fixed-price contract. This award represents a non-set-aside, competitively awarded delivery order with a completion date of September 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Nucynta ER 50 mg tablets (60-count), with a contract ceiling value of $1,398.37. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award to the contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units) at a ceiling value of $3,670.09. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a contract ceiling value of $1,666.05. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 50 mg tablets (60-count) on September 22, 2025, with a ceiling value of $1,094.75 and an ultimate completion date of September 23, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Nucynta 50 mg tablets (100-count units) with a ceiling value of $1,225.04. This is a firm fixed-price delivery order with an ultimate completion date of May 5, 2025, and represents a non-competitive set-aside award. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,694.17 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. The award falls under AmerisourceBergen's existing Indefinite...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB26FANURDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Nucynta ER 50 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,724.40. This competitively awarded, non-set-aside delivery order is scheduled for completion by October 17, 2025, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the vendor's role as a critical pharmaceutical supplier to the federal government's medical procurement system. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor vehicle enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally, including medications across multiple therapeutic domains, vaccines, and medical supplies. AmerisourceBergen's position as a major pharmaceutical distributor and established federal contractor demonstrates its capability to meet the Defense Logistics Agency's medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 10/16/25 |